In the present study, we showed, by using small-molecule inhibitors, that the TGF-β pathway, as well as three of the top upregulated genes from our gene-expression profile, are functionally required for invasion and tumor cell dissemination in vivo in both cell-line and patient-derived primary breast tumors. The gene discussed is TGFB1; the disease is breast neoplasm.